Phibro Animal Health PAHC Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Animal Health | $962.8M+36.3% | $706.48M+7.1% | $659.85M+8.7% | $607.06M+11.2% | |
| Mineral Nutrition | $253.24M+3.9% | $243.66M+0.4% | $242.66M-6.5% | $259.51M+17.7% | |
| Performance Products | $80.18M+18.7% | $67.53M-10.4% | $75.38M-0.4% | $75.69M+12.9% | |
| Revenue by Product | |||||
| Medicated Feed Additives And Others | $646.35M+53.5% | $420.96M+8.7% | $387.35M+7.1% | $361.54M+9.6% | |
| Mineral Nutrition | $253.24M+3.9% | $243.66M+0.4% | $242.66M-6.5% | $259.51M+17.7% | |
| Nutritional Specialties | $179.29M+8.9% | $164.67M-4.5% | $172.5M+9.7% | $157.2M+10.1% | |
| Performance Products | $80.18M+18.7% | $67.53M-10.4% | $75.38M-0.4% | $75.69M+12.9% | |
| Vaccines | $137.15M+13.5% | $120.85M+20.9% | $100M+13.2% | $88.32M+21.1% | |
| Revenue by Geography | |||||
| Asia Pacific | $97.42M+54.1% | $63.23M+2.9% | $61.45M-8.2% | $66.93M+15.4% | |
| EMEA | $160.23M+31.4% | $121.98M+3.5% | $117.82M-3.8% | $122.49M+7.3% | |
| Latin America And Canada | $298.65M+20.6% | $247.71M+12.7% | $219.85M+15.1% | $191.05M+14.9% | |
| US | $739.92M+26.5% | $584.76M+1.0% | $578.78M+3.0% | $561.8M+13.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Phibro Animal Health break its business down?
- Phibro Animal Health (PAHC) reports revenue by business across 3 parts — Animal Health, Mineral Nutrition and Performance Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Phibro Animal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Phibro Animal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
